WAYNE, Pa., July 22, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Save the Date! Safeguard Scientifics, Inc. (NYSE: SFE ) will be hosting its 8th Annual Investor Day at the New York Stock Exchange on Wednesday, October 15, 2014 from 8:00am–12:00pm EDT.
Investor Day 2014 will offer the investor community an opportunity to hear from Safeguard's executive team, along with executives from Safeguard's partner companies, about growth opportunities and value creation strategies. Partner companies that are currently scheduled to present include, alphabetically:
Please note that presenting partner companies are subject to change.
ONE-ON-ONES: If you are interested in meeting one-on-one with members of Safeguard's executive team or Safeguard's partner companies, please contact John E. Shave III, Senior Vice President, Corporate Communications and Investor Relations at (610) 975-4952 or jshave(at)safeguard(dot)com.
RSVP: For additional information and/or to RSVP, please contact us at (610) 975-4952, IR(at)safeguard(dot)com or register online at http://www.safeguard.com/InvestorDay2014 .
About Safeguard Scientifics
Safeguard Scientifics, Inc. (NYSE: SFE ) has a distinguished track record of fostering innovation and building market leaders. For six decades, Safeguard has been providing growth capital and operational support to entrepreneurs across an evolving spectrum of industries. Today, Safeguard is focused specifically on two sectors--healthcare and technology. Recent successful exits include Alverix (acquired by Becton, Dickinson for $40 million); Crescendo Bioscience (acquired by Myriad Genetics for $270 million); NuPathe (acquired by Teva Pharmaceutical Industries for $144 million); and ThingWorx (acquired by PTC for initial proceeds of $112 million). For more information, please visit http://www.safeguard.com or Follow Us on Twitter @safeguard.
Forward-looking Statements
Except for the historical information and discussions contained herein, statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements are subject to risks and uncertainties. The risks and uncertainties that could cause actual results to differ materially include, among others, our ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, our substantial capital requirements and absence of liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our partner companies, including the fact that most of our partner companies have a limited history and a history of operating losses, face intense competition and may never be profitable, the effect of economic conditions in the business sectors in which Safeguard's partner companies operate, and other uncertainties described in our filings with the Securities and Exchange Commission. Many of these factors are beyond the Company's ability to predict or control. As a result of these and other factors, the Company's past financial performance should not be relied on as an indication of future performance. The Company does not assume any obligation to update any forward-looking statements or other information contained in this press release.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/07/prweb12027152.htm
Safeguard Scientifics John E. Shave III +1 610.975.4952
